Carregant...
Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage
BACKGROUND: Severe or massive postpartum hemorrhage (PPH) has remained a leading cause of maternal mortality for decades across the world and it results in critical obstetric complications. Recombinant activated factor VII (rFVIIa) has emerged as a gold standard adjunctive hemostatic agent for the t...
Guardat en:
| Publicat a: | Korean J Crit Care Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean Society of Critical Care Medicine
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6786683/ https://ncbi.nlm.nih.gov/pubmed/31723654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4266/kjccm.2016.00787 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|